Free Trial
→ It’s Time to Buy “the NVIDIA of Quantum Computing” (From Brownstone Research) (Ad)tc pixel Free FLDM Stock Alerts

This company has been marked as potentially delisted and may not be actively trading.

Fluidigm (FLDM) Financials

Fluidigm logo
Compare
Annual Income Statements for Fluidigm

Annual Income Statements for Fluidigm

This table shows Fluidigm's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -59 -190 -75 -185
Consolidated Net Income / (Loss)		 -59 -190 -75 -139
Net Income / (Loss) Continuing Operations		 -59 -190 -75 -139
Total Pre-Tax Income 		-64 -193 -74 -138
Total Operating Income		 -67 -116 -77 -175
Total Gross Profit		 69 37 50 84
Total Revenue		 131 98 106 174
Operating Revenue		 131 98 106 174
Total Cost of Revenue		 61 61 56 90
Operating Cost of Revenue		 61 61 56 90
Total Operating Expenses		 137 153 127 259
Selling, General & Admin Expense		 99 102 88 157
Research & Development Expense		 38 37 26 62
Restructuring Charge		 - 14 14 40
Total Other Income / (Expense), net		 3.80 -77 2.40 37
Interest Expense		 3.82 4.33 4.57 3.32
Interest & Investment Income		 0.00 2.23 5.57 20
Other Income / (Expense), net		 7.62 -75 1.39 20
Income Tax Expense		 -4.42 -2.83 0.45 0.57
Preferred Stock Dividends Declared		 - 0.00 0.00 46
Basic Earnings per Share		 ($0.78) ($2.43) ($0.94) ($0.52)
Weighted Average Basic Shares Outstanding		 75.79M 78.31M 79.16M 353.25M
Diluted Earnings per Share		 ($0.78) ($2.43) ($0.94) ($0.52)
Weighted Average Diluted Shares Outstanding		 75.79M 78.31M 79.16M 353.25M
Weighted Average Basic & Diluted Shares Outstanding		 77.20M 79.06M 290.12M 378.99M

Quarterly Income Statements for Fluidigm

This table shows Fluidigm's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q2 2024 Q3 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 6/30/2024 9/30/2024
Net Income / (Loss) Attributable to Common Shareholders		 -29 -21 -17 -17 -21 -20 -46 -27
Consolidated Net Income / (Loss)		 -29 -21 -17 -17 -21 -20 -46 -27
Net Income / (Loss) Continuing Operations		 -29 -21 -17 -17 -21 -20 -46 -27
Total Pre-Tax Income 		-30 -21 -17 -17 -21 -20 -46 -27
Total Operating Income		 -29 -21 -17 -17 -21 -21 -51 -32
Total Gross Profit		 9.22 11 12 14 11 13 15 23
Total Revenue		 26 27 25 28 25 28 37 45
Operating Revenue		 26 27 25 28 25 28 37 45
Total Cost of Revenue		 16 16 13 14 14 15 22 22
Operating Cost of Revenue		 16 16 13 14 14 15 22 22
Total Operating Expenses		 38 32 29 31 32 35 65 55
Selling, General & Admin Expense		 26 15 21 23 22 21 38 34
Research & Development Expense		 8.49 7.43 6.43 6.18 6.37 6.97 19 13
Restructuring Charge		 3.42 - 1.15 2.27 3.66 6.48 8.53 7.42
Total Other Income / (Expense), net		 -1.11 0.34 0.01 0.71 0.23 1.45 4.86 4.90
Interest & Investment Income		 0.00 62 0.07 0.24 0.34 4.92 4.44 3.94
Other Income / (Expense), net		 -0.06 -61 -0.06 0.47 -0.12 1.10 0.41 0.96
Income Tax Expense		 -0.71 0.07 0.26 0.30 0.05 -0.16 0.06 0.12
Preferred Stock Dividends Declared		 - - 0.00 0.00 0.00 - 0.00 0.00
Basic Earnings per Share		 ($0.37) ($0.25) ($0.21) ($0.22) ($0.27) ($0.24) ($0.12) ($0.07)
Weighted Average Basic Shares Outstanding		 78.90M 78.31M 79.08M 78.67M 79.15M 79.16M 372.33M 371.54M
Diluted Earnings per Share		 ($0.37) ($0.25) ($0.21) ($0.22) ($0.27) ($0.24) ($0.12) ($0.07)
Weighted Average Diluted Shares Outstanding		 78.90M 78.31M 79.08M 78.67M 79.15M 79.16M 372.33M 371.54M
Weighted Average Basic & Diluted Shares Outstanding		 79.30M 79.06M 78.38M 78.96M 79.40M 290.12M 371.15M 372.26M

Annual Cash Flow Statements for Fluidigm

This table details how cash moves in and out of Fluidigm's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -40 53 -30 116
Net Cash From Operating Activities		 -44 -89 -43 -143
Net Cash From Continuing Operating Activities		 -44 -89 -43 -143
Net Income / (Loss) Continuing Operations		 -59 -190 -75 -139
Consolidated Net Income / (Loss)		 -59 -190 -75 -139
Depreciation Expense		 3.65 3.50 3.98 13
Amortization Expense		 13 11 9.94 -3.09
Non-Cash Adjustments To Reconcile Net Income		 18 101 15 8.31
Changes in Operating Assets and Liabilities, net		 -19 -14 2.73 -22
Net Cash From Investing Activities		 -12 -88 20 363
Net Cash From Continuing Investing Activities		 -12 -88 20 363
Purchase of Property, Plant & Equipment		 -13 -3.83 -2.83 -8.36
Acquisitions		 - 0.00 0.00 -1.39
Purchase of Investments		 0.00 -137 -95 -256
Sale and/or Maturity of Investments		 0.00 53 118 349
Other Investing Activities, net		 1.32 0.00 0.00 280
Net Cash From Financing Activities		 16 231 -6.81 -103
Net Cash From Continuing Financing Activities		 16 231 -6.81 -103
Repayment of Debt		 -0.50 -6.84 -2.08 -64
Repurchase of Common Equity		 -0.08 -13 -5.41 -40
Issuance of Debt		 17 25 0.00 0.00
Issuance of Preferred Equity		 0.00 225 0.00 0.00
Issuance of Common Equity		 1.49 0.82 0.72 0.92
Other Financing Activities, net		 -1.79 -0.11 -0.04 0.69
Effect of Exchange Rate Changes		 -0.02 -0.40 0.03 -0.79
Cash Interest Paid		 3.15 3.49 3.82 3.09
Cash Income Taxes Paid		 2.09 0.31 0.80 0.61

Quarterly Cash Flow Statements for Fluidigm

This table details how cash moves in and out of Fluidigm's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 9/30/2024 12/31/2024
Net Change in Cash & Equivalents		 -14 21 32 29 -63 -28 -59 -43
Net Cash From Operating Activities		 -25 -19 -8.49 -9.33 -11 -14 -28 -14
Net Cash From Continuing Operating Activities		 -25 -19 -8.49 -9.33 -11 -14 -28 -14
Net Income / (Loss) Continuing Operations		 -29 -21 -17 -17 -21 -20 -27 -34
Consolidated Net Income / (Loss)		 -29 -21 -17 -17 -21 -20 -27 -34
Depreciation Expense		 0.80 0.82 0.86 0.83 1.19 1.11 3.15 3.14
Amortization Expense		 3.01 1.50 2.64 2.81 2.63 1.86 -1.05 -0.32
Non-Cash Adjustments To Reconcile Net Income		 7.14 2.76 3.54 3.36 6.60 1.23 10 3.40
Changes in Operating Assets and Liabilities, net		 -6.13 -3.42 1.32 0.71 -0.83 1.52 -13 14
Net Cash From Investing Activities		 11 40 43 40 -50 -13 -31 26
Net Cash From Continuing Investing Activities		 11 40 43 40 -50 -13 -31 26
Purchase of Property, Plant & Equipment		 -1.26 -0.76 -1.01 -0.84 -0.91 -0.08 -2.26 -3.38
Purchase of Investments		 - - -6.84 - -49 -39 -79 -30
Sale and/or Maturity of Investments		 12 41 51 41 - 26 50 60
Net Cash From Financing Activities		 -0.01 -0.27 -2.56 -2.08 -1.16 -1.00 -0.00 -55
Net Cash From Continuing Financing Activities		 -0.01 -0.27 -2.56 -2.08 -1.16 -1.00 -0.00 -55
Repayment of Debt		 - - 0.00 - -0.83 -1.25 - -55
Issuance of Common Equity		 - 0.32 - - - 0.40 - 0.49
Other Financing Activities, net		 -0.01 -0.03 -0.09 -0.04 0.07 0.02 -0.00 -0.01
Effect of Exchange Rate Changes		 -0.28 0.32 0.02 -0.07 -0.15 0.23 -0.41 -0.27
Cash Interest Paid		 0.17 1.65 0.23 1.69 0.25 1.65 0.00 1.44
Cash Income Taxes Paid		 -0.39 0.06 0.31 0.21 0.12 0.17 0.06 0.20

Annual Balance Sheets for Fluidigm

This table presents Fluidigm's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 275 390 323 612
Total Current Assets		 72 209 158 376
Cash & Equivalents		 28 81 52 167
Short-Term Investments		 0.00 84 63 126
Accounts Receivable		 18 17 20 34
Inventories, net		 21 21 21 41
Prepaid Expenses		 4.47 4.28 3.13 8.66
Plant, Property, & Equipment, net		 28 26 24 43
Total Noncurrent Assets		 175 156 141 194
Goodwill		 106 106 106 111
Intangible Assets		 28 13 1.40 29
Other Noncurrent Operating Assets		 41 37 33 54
Total Liabilities & Shareholders' Equity		 275 390 323 612
Total Liabilities		 181 161 160 141
Total Current Liabilities		 50 43 109 66
Short-Term Debt		 6.84 2.08 60 0.00
Accounts Payable		 11 7.91 9.24 12
Accrued Expenses		 8.67 6.18 21 31
Current Deferred Revenue		 15 14 15 17
Other Current Liabilities		 3.05 3.68 4.32 6.23
Total Noncurrent Liabilities		 131 117 51 75
Long-Term Debt		 64 63 3.98 0.30
Noncurrent Deferred Revenue		 5.97 3.82 3.52 33
Noncurrent Deferred & Payable Income Tax Liabilities		 4.33 1.06 0.84 1.08
Other Noncurrent Operating Liabilities		 57 49 42 41
Commitments & Contingencies		 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 0.00 311 311 0.00
Total Equity & Noncontrolling Interests		 95 -81 -148 472
Total Preferred & Common Equity		 95 -81 -148 472
Preferred Stock		 0.00 0.00 0.00 0.00
Total Common Equity		 95 -81 -148 472
Common Stock		 832 847 861 1,703
Retained Earnings		 -736 -926 -1,001 -1,186
Treasury Stock		 0.00 -0.56 -5.98 -46
Accumulated Other Comprehensive Income / (Loss)		 -0.91 -1.90 -2.22 1.23

Quarterly Balance Sheets for Fluidigm

This table presents Fluidigm's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q2 2024 Q3 2024
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 6/30/2024 9/30/2024
Total Assets		 415 372 356 339 709 682
Total Current Assets		 229 195 183 171 480 454
Cash & Equivalents		 60 114 142 80 270 211
Short-Term Investments		 125 41 0.00 49 125 156
Accounts Receivable		 17 15 15 17 32 35
Inventories, net		 22 23 22 22 43 43
Prepaid Expenses		 4.61 3.37 3.57 3.40 10 9.32
Plant, Property, & Equipment, net		 27 25 25 25 43 42
Total Noncurrent Assets		 159 152 148 144 186 186
Goodwill		 106 106 106 106 106 106
Intangible Assets		 15 9.80 7.00 4.20 24 23
Other Noncurrent Operating Assets		 38 36 35 34 56 56
Total Liabilities & Shareholders' Equity		 415 372 356 339 709 682
Total Liabilities		 166 158 158 160 198 192
Total Current Liabilities		 46 44 47 52 124 121
Short-Term Debt		 0.83 3.33 4.58 5.00 55 55
Accounts Payable		 9.31 6.11 6.09 7.33 13 11
Accrued Expenses		 6.91 6.88 7.18 10 32 32
Current Deferred Revenue		 15 15 15 15 19 17
Other Current Liabilities		 3.52 3.76 3.91 3.98 5.85 6.12
Total Noncurrent Liabilities		 120 114 111 108 75 72
Long-Term Debt		 64 62 61 60 0.30 0.30
Noncurrent Deferred Revenue		 4.43 3.83 3.79 3.47 33 33
Noncurrent Deferred & Payable Income Tax Liabilities		 0.62 1.05 1.05 1.02 0.84 0.84
Other Noncurrent Operating Liabilities		 51 47 46 44 40 38
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 311 311 311 311 0.00 0.00
Total Equity & Noncontrolling Interests		 -63 -97 -113 -132 510 489
Total Preferred & Common Equity		 -63 -97 -113 -132 510 489
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 -63 -97 -113 -132 510 489
Common Stock		 845 850 854 857 1,683 1,689
Retained Earnings		 -905 -943 -960 -981 -1,125 -1,152
Treasury Stock		 - -3.03 -5.40 -5.80 -46 -46
Accumulated Other Comprehensive Income / (Loss)		 -2.61 -1.33 -1.55 -1.95 -1.50 -1.41

Annual Metrics And Ratios for Fluidigm

This table displays calculated financial ratios and metrics derived from Fluidigm's official financial filings.

Metric 2021 2022 2023 2024
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - -
Revenue Growth		 -5.47% -24.99% 8.57% 64.03%
EBITDA Growth		 -36.20% -304.36% 65.27% -137.83%
EBIT Growth		 -18.42% -218.90% 60.59% -106.35%
NOPAT Growth		 -32.18% -72.26% 34.08% -128.77%
Net Income Growth		 -11.73% -220.91% 60.73% -86.03%
EPS Growth		 -5.41% -211.54% 61.32% 44.68%
Operating Cash Flow Growth		 -185.79% -102.83% 51.56% -231.40%
Free Cash Flow Firm Growth		 -410.55% -22.44% 49.97% -419.87%
Invested Capital Growth		 9.97% -6.05% -13.25% 60.21%
Revenue Q/Q Growth		 -4.63% -10.30% 1.11% 0.00%
EBITDA Q/Q Growth		 13.42% -73.03% -2.61% 0.00%
EBIT Q/Q Growth		 10.44% -61.57% -0.94% 0.00%
NOPAT Q/Q Growth		 7.72% -9.26% -0.36% 0.00%
Net Income Q/Q Growth		 12.67% -6.39% 1.41% 0.00%
EPS Q/Q Growth		 14.29% -5.65% 1.05% 0.00%
Operating Cash Flow Q/Q Growth		 -8.01% -15.78% 10.58% 0.00%
Free Cash Flow Firm Q/Q Growth		 -15.85% -6.74% 10.09% 0.00%
Invested Capital Q/Q Growth		 2.33% 0.65% -3.00% 0.00%
Profitability Metrics		 - - - -
Gross Margin		 53.13% 37.83% 47.44% 48.31%
EBITDA Margin		 -33.42% -180.17% -57.64% -83.57%
Operating Margin		 -51.66% -118.64% -72.03% -100.46%
EBIT Margin		 -45.82% -194.82% -70.73% -88.97%
Profit (Net Income) Margin		 -45.36% -194.08% -70.21% -79.62%
Tax Burden Percent		 93.05% 98.53% 100.61% 100.41%
Interest Burden Percent		 106.39% 101.10% 98.66% 89.12%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -36.05% -61.14% -44.55% -84.32%
ROIC Less NNEP Spread (ROIC-NNEP)		 -120.97% 311.97% -16.92% -74.88%
Return on Net Nonoperating Assets (RNNOA)		 -14.65% -56.07% 6.56% 40.57%
Return on Equity (ROE)		 -50.71% -117.21% -37.99% -43.75%
Cash Return on Invested Capital (CROIC)		 -45.55% -54.90% -30.36% -130.59%
Operating Return on Assets (OROA)		 -19.95% -57.35% -21.09% -33.18%
Return on Assets (ROA)		 -19.75% -57.13% -20.93% -29.70%
Return on Common Equity (ROCE)		 -50.71% -4.74% 22.19% -22.30%
Return on Equity Simple (ROE_SIMPLE)		 -62.62% 233.34% 50.43% -29.44%
Net Operating Profit after Tax (NOPAT)		 -47 -81 -54 -123
NOPAT Margin		 -36.16% -83.05% -50.42% -70.32%
Net Nonoperating Expense Percent (NNEP)		 84.92% -373.11% -27.63% -9.43%
Return On Investment Capital (ROIC_SIMPLE)		 - 490.76% 63.43% -25.99%
Cost of Revenue to Revenue		 46.87% 62.17% 52.56% 51.69%
SG&A Expenses to Revenue		 75.73% 104.43% 82.32% 89.78%
R&D to Revenue		 29.06% 38.17% 24.40% 35.78%
Operating Expenses to Revenue		 104.79% 156.47% 119.48% 148.77%
Earnings before Interest and Taxes (EBIT)		 -60 -191 -75 -155
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -44 -176 -61 -146
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 3.17 0.00 0.00 1.38
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 1.97
Price to Revenue (P/Rev)		 2.30 0.95 1.65 3.73
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 2.50 2.35 3.89 2.00
Enterprise Value to Revenue (EV/Rev)		 2.62 3.09 4.09 2.06
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - -
Debt to Equity		 0.75 0.28 0.39 0.00
Long-Term Debt to Equity		 0.68 0.27 0.02 0.00
Financial Leverage		 0.12 -0.18 -0.39 -0.54
Leverage Ratio		 2.57 2.05 1.82 1.47
Compound Leverage Factor		 2.73 2.07 1.79 1.31
Debt to Total Capital		 42.89% 22.02% 28.01% 0.06%
Short-Term Debt to Total Capital		 4.13% 0.71% 26.26% 0.00%
Long-Term Debt to Total Capital		 38.76% 21.31% 1.76% 0.06%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 105.62% 137.29% 0.00%
Common Equity to Total Capital		 57.11% -27.65% -65.30% 99.94%
Debt to EBITDA		 -1.63 -0.37 -1.04 0.00
Net Debt to EBITDA		 -0.98 0.57 0.84 2.01
Long-Term Debt to EBITDA		 -1.47 -0.36 -0.07 0.00
Debt to NOPAT		 -1.50 -0.80 -1.18 0.00
Net Debt to NOPAT		 -0.90 1.24 0.96 2.39
Long-Term Debt to NOPAT		 -1.36 -0.77 -0.07 0.00
Altman Z-Score		 -2.89 -3.83 -3.94 0.12
Noncontrolling Interest Sharing Ratio		 0.00% 95.95% 158.40% 49.02%
Liquidity Ratios		 - - - -
Current Ratio		 1.45 4.81 1.45 5.70
Quick Ratio		 0.94 4.21 1.23 4.95
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 -60 -73 -37 -190
Operating Cash Flow to CapEx		 -332.18% -2,336.47% -1,529.04% -1,716.98%
Free Cash Flow to Firm to Interest Expense		 -15.61 -16.87 -8.00 -57.30
Operating Cash Flow to Interest Expense		 -11.53 -20.64 -9.48 -43.26
Operating Cash Flow Less CapEx to Interest Expense		 -14.99 -21.52 -10.10 -45.78
Efficiency Ratios		 - - - -
Asset Turnover		 0.44 0.29 0.30 0.37
Accounts Receivable Turnover		 5.97 5.50 5.76 6.55
Inventory Turnover		 3.02 2.88 2.66 2.94
Fixed Asset Turnover		 5.73 3.65 4.27 5.23
Accounts Payable Turnover		 6.18 6.58 6.52 8.38
Days Sales Outstanding (DSO)		 61.14 66.33 63.40 55.73
Days Inventory Outstanding (DIO)		 120.80 126.76 137.16 124.01
Days Payable Outstanding (DPO)		 59.10 55.49 56.00 43.55
Cash Conversion Cycle (CCC)		 122.83 137.60 144.56 136.19
Capital & Investment Metrics		 - - - -
Invested Capital		 137 129 112 179
Invested Capital Turnover		 1.00 0.74 0.88 1.20
Increase / (Decrease) in Invested Capital		 12 -8.30 -17 67
Enterprise Value (EV)		 342 303 435 359
Market Capitalization		 300 93 175 651
Book Value per Share		 $1.24 ($1.03) ($1.86) $1.27
Tangible Book Value per Share		 ($0.52) ($2.53) ($3.22) $0.89
Total Capital		 166 295 227 472
Total Debt		 71 65 64 0.30
Total Long-Term Debt		 64 63 3.98 0.30
Net Debt		 43 -101 -51 -293
Capital Expenditures (CapEx)		 13 3.83 2.83 8.36
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.89 1.67 -6.48 17
Debt-free Net Working Capital (DFNWC)		 29 167 108 310
Net Working Capital (NWC)		 22 165 49 310
Net Nonoperating Expense (NNE)		 12 109 21 16
Net Nonoperating Obligations (NNO)		 43 -101 -51 -293
Total Depreciation and Amortization (D&A)		 16 14 14 9.43
Debt-free, Cash-free Net Working Capital to Revenue		 0.68% 1.71% -6.09% 9.81%
Debt-free Net Working Capital to Revenue		 22.47% 170.96% 101.95% 177.71%
Net Working Capital to Revenue		 17.23% 168.84% 45.97% 177.71%
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 ($0.78) ($2.43) ($0.94) ($0.52)
Adjusted Weighted Average Basic Shares Outstanding		 75.79M 78.31M 79.16M 353.25M
Adjusted Diluted Earnings per Share		 ($0.78) ($2.43) ($0.94) ($0.52)
Adjusted Weighted Average Diluted Shares Outstanding		 75.79M 78.31M 79.16M 353.25M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 77.20M 79.06M 290.12M 378.99M
Normalized Net Operating Profit after Tax (NOPAT)		 -47 -72 -44 -94
Normalized NOPAT Margin		 -36.16% -73.34% -41.50% -54.08%
Pre Tax Income Margin		 -48.75% -196.97% -69.78% -79.29%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 -15.65 -44.06 -16.47 -46.80
NOPAT to Interest Expense		 -12.35 -18.78 -11.74 -36.99
EBIT Less CapEx to Interest Expense		 -19.12 -44.94 -17.09 -49.32
NOPAT Less CapEx to Interest Expense		 -15.82 -19.66 -12.36 -39.51
Payout Ratios		 - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -0.13% -6.90% -7.25% -29.15%

Quarterly Metrics And Ratios for Fluidigm

This table displays calculated financial ratios and metrics derived from Fluidigm's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q2 2024 Q3 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 6/30/2024 9/30/2024
Growth Metrics		 - - - - - - - -
Revenue Growth		 -10.03% -29.38% -5.23% 47.34% -1.09% 4.32% 34.48% 77.27%
EBITDA Growth		 -147.65% -1,463.05% 61.15% 64.66% 30.90% 78.23% -275.53% -64.05%
EBIT Growth		 -103.47% -792.95% 56.23% 59.37% 26.82% 75.23% -195.04% -44.51%
NOPAT Growth		 -48.01% -87.51% 39.67% 54.75% 27.06% -1.30% -189.52% -49.81%
Net Income Growth		 -112.57% -121.05% 77.92% 73.18% 28.64% 5.13% -168.30% -28.29%
EPS Growth		 -105.56% -108.33% 78.79% 73.17% 27.03% 4.00% 45.45% 74.07%
Operating Cash Flow Growth		 -159.23% -173.94% 45.57% 68.89% 53.63% 26.69% 0.00% -144.21%
Free Cash Flow Firm Growth		 -1.79% 68.11% -382.28% 72.74% 85.76% 132.46% -1,346.95% -4,079.08%
Invested Capital Growth		 -4.49% -6.05% 35.23% -4.98% -9.98% -13.25% 41.24% 54.60%
Revenue Q/Q Growth		 36.58% 5.36% -7.04% 10.14% -8.31% 11.12% 0.00% 20.87%
EBITDA Q/Q Growth		 33.03% -214.74% 16.55% -1.43% -30.94% 0.86% 0.00% 42.80%
EBIT Q/Q Growth		 30.41% -181.51% 14.98% -1.99% -25.34% 4.70% 0.00% 38.61%
NOPAT Q/Q Growth		 24.73% 27.27% 21.40% -5.16% -21.34% -1.01% 0.00% 37.22%
Net Income Q/Q Growth		 53.69% 29.16% 19.20% -1.17% -23.22% 5.82% 0.00% 41.08%
EPS Q/Q Growth		 54.88% 32.43% 16.00% -4.76% -22.73% 11.11% 0.00% 41.67%
Operating Cash Flow Q/Q Growth		 17.93% 22.06% 55.76% -9.95% -22.33% -23.21% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 33.78% 54.69% -580.25% 86.65% 65.39% 203.26% 0.00% 0.05%
Invested Capital Q/Q Growth		 0.73% 0.65% -3.31% -3.07% -4.58% -3.00% 0.00% 4.45%
Profitability Metrics		 - - - - - - - -
Gross Margin		 35.95% 41.33% 48.89% 49.17% 43.97% 47.58% 40.07% 51.73%
EBITDA Margin		 -98.58% -294.49% -52.37% -48.23% -68.87% -61.45% -134.68% -63.74%
Operating Margin		 -113.18% -78.13% -66.06% -63.07% -83.46% -75.87% -135.79% -70.53%
EBIT Margin		 -113.43% -303.07% -66.29% -61.39% -83.92% -71.97% -134.68% -68.40%
Profit (Net Income) Margin		 -114.74% -77.14% -67.05% -61.59% -82.77% -70.16% -122.88% -59.90%
Tax Burden Percent		 97.63% 100.34% 101.59% 101.80% 100.24% 99.19% 100.12% 100.44%
Interest Burden Percent		 103.61% 25.37% 99.57% 98.56% 98.40% 98.28% 91.13% 87.19%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -66.01% -40.27% -41.19% -37.55% -50.50% -46.92% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -44.76% -19.45% 12.65% -33.24% -43.82% -40.61% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 11.03% 3.50% -1.04% 15.77% 18.91% 15.74% 0.00% 0.00%
Return on Equity (ROE)		 -54.98% -36.77% -42.23% -21.79% -31.60% -31.19% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)		 -52.21% -54.90% -97.95% -42.43% -33.41% -30.36% 0.00% 0.00%
Operating Return on Assets (OROA)		 -35.53% -89.21% -19.89% -16.25% -23.40% -21.46% 0.00% 0.00%
Return on Assets (ROA)		 -35.94% -22.71% -20.12% -16.30% -23.09% -20.92% 0.00% 0.00%
Return on Common Equity (ROCE)		 -5.78% -1.49% 13.42% 6.97% 14.36% 18.21% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 284.77% 0.00% 134.48% 74.22% 57.49% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -20 -15 -12 -12 -15 -15 -35 -22
NOPAT Margin		 -79.23% -54.69% -46.24% -44.15% -58.42% -53.11% -95.05% -49.37%
Net Nonoperating Expense Percent (NNEP)		 -21.25% -20.81% -53.84% -4.31% -6.69% -6.31% -4.97% -2.52%
Cost of Revenue to Revenue		 64.05% 58.67% 51.11% 50.84% 56.03% 52.42% 59.93% 48.27%
SG&A Expenses to Revenue		 102.71% 55.46% 84.78% 81.69% 87.88% 75.76% 101.26% 76.50%
R&D to Revenue		 33.09% 27.48% 25.59% 22.35% 25.11% 24.71% 51.67% 29.26%
Operating Expenses to Revenue		 149.13% 119.46% 114.95% 112.24% 127.43% 123.45% 175.86% 122.26%
Earnings before Interest and Taxes (EBIT)		 -29 -82 -17 -17 -21 -20 -50 -31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -25 -80 -13 -13 -17 -17 -50 -29
Valuation Ratios		 - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 0.00 0.00 1.29 1.46
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 1.73 1.99
Price to Revenue (P/Rev)		 0.79 0.95 1.60 1.43 2.18 1.65 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 2.17 2.35 3.02 3.19 4.13 3.89 1.87 2.27
Enterprise Value to Revenue (EV/Rev)		 2.54 3.09 3.89 3.66 4.53 4.09 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - -
Debt to Equity		 0.26 0.28 0.30 0.33 0.36 0.39 0.11 0.11
Long-Term Debt to Equity		 0.26 0.27 0.29 0.31 0.33 0.02 0.00 0.00
Financial Leverage		 -0.25 -0.18 -0.08 -0.47 -0.43 -0.39 -0.59 -0.56
Leverage Ratio		 2.00 2.05 2.72 1.69 1.76 1.82 1.50 1.53
Compound Leverage Factor		 2.08 0.52 2.71 1.67 1.73 1.78 1.37 1.33
Debt to Total Capital		 20.66% 22.02% 23.31% 24.80% 26.46% 28.01% 9.74% 10.14%
Short-Term Debt to Total Capital		 0.27% 0.71% 1.19% 1.74% 2.05% 26.26% 9.69% 10.08%
Long-Term Debt to Total Capital		 20.40% 21.31% 22.11% 23.06% 24.41% 1.76% 0.05% 0.05%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 99.37% 105.62% 111.49% 118.30% 127.50% 137.29% 0.00% 0.00%
Common Equity to Total Capital		 -20.03% -27.65% -34.80% -43.09% -53.96% -65.30% 90.26% 89.86%
Debt to EBITDA		 -0.63 -0.37 -0.71 -0.97 -1.08 -1.04 0.00 0.00
Net Debt to EBITDA		 1.18 0.57 0.97 1.14 1.08 0.84 0.00 0.00
Long-Term Debt to EBITDA		 -0.63 -0.36 -0.67 -0.90 -1.00 -0.07 0.00 0.00
Debt to NOPAT		 -0.87 -0.80 -0.88 -1.11 -1.21 -1.18 0.00 0.00
Net Debt to NOPAT		 1.62 1.24 1.21 1.31 1.20 0.96 0.00 0.00
Long-Term Debt to NOPAT		 -0.86 -0.77 -0.84 -1.03 -1.12 -0.07 0.00 0.00
Altman Z-Score		 -2.18 -2.91 -2.36 -2.60 -2.66 -3.37 0.00 0.00
Noncontrolling Interest Sharing Ratio		 89.48% 95.95% 131.77% 131.98% 145.43% 158.40% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - -
Current Ratio		 4.96 4.81 4.45 3.91 3.30 1.45 3.88 3.76
Quick Ratio		 4.39 4.21 3.86 3.36 2.81 1.23 3.45 3.33
Cash Flow Metrics		 - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -14 -6.48 -44 -5.89 -2.04 2.10 -85 -85
Operating Cash Flow to CapEx		 -1,947.07% -2,540.53% -840.10% -1,113.25% -1,260.99% -18,026.92% 0.00% -1,235.88%
Free Cash Flow to Firm to Interest Expense		 -13.63 -5.45 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 -23.46 -16.12 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -24.67 -16.75 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - -
Asset Turnover		 0.31 0.29 0.30 0.26 0.28 0.30 0.00 0.00
Accounts Receivable Turnover		 7.04 5.50 6.45 8.09 6.21 5.76 0.00 0.00
Inventory Turnover		 2.72 2.88 2.60 2.64 2.60 2.66 0.00 0.00
Fixed Asset Turnover		 3.94 3.65 3.66 4.07 4.11 4.27 0.00 0.00
Accounts Payable Turnover		 6.28 6.58 6.39 7.84 6.85 6.52 0.00 0.00
Days Sales Outstanding (DSO)		 51.86 66.33 56.56 45.09 58.74 63.40 0.00 0.00
Days Inventory Outstanding (DIO)		 134.40 126.76 140.43 138.37 140.55 137.16 0.00 0.00
Days Payable Outstanding (DPO)		 58.14 55.49 57.16 46.58 53.28 56.00 0.00 0.00
Cash Conversion Cycle (CCC)		 128.12 137.60 139.82 136.88 146.01 144.56 0.00 0.00
Capital & Investment Metrics		 - - - - - - - -
Invested Capital		 128 129 125 121 115 112 171 178
Invested Capital Turnover		 0.83 0.74 0.89 0.85 0.86 0.88 0.00 0.00
Increase / (Decrease) in Invested Capital		 -6.02 -8.30 32 -6.33 -13 -17 50 63
Enterprise Value (EV)		 277 303 376 385 476 435 319 405
Market Capitalization		 87 93 154 151 229 175 659 716
Book Value per Share		 ($0.80) ($1.03) ($1.23) ($1.45) ($1.67) ($1.86) $1.37 $1.32
Tangible Book Value per Share		 ($2.34) ($2.53) ($2.70) ($2.89) ($3.07) ($3.22) $1.02 $0.97
Total Capital		 313 295 279 263 244 227 565 545
Total Debt		 65 65 65 65 65 64 55 55
Total Long-Term Debt		 64 63 62 61 60 3.98 0.30 0.30
Net Debt		 -120 -101 -89 -77 -64 -51 -340 -311
Capital Expenditures (CapEx)		 1.26 0.76 1.01 0.84 0.91 0.08 0.00 2.26
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -1.49 1.67 -0.06 -1.49 -4.91 -6.48 16 22
Debt-free Net Working Capital (DFNWC)		 184 167 154 141 124 108 411 388
Net Working Capital (NWC)		 183 165 151 136 119 49 356 333
Net Nonoperating Expense (NNE)		 9.11 6.07 5.23 4.83 6.18 4.81 10 4.74
Net Nonoperating Obligations (NNO)		 -120 -101 -89 -77 -64 -51 -340 -311
Total Depreciation and Amortization (D&A)		 3.81 2.32 3.50 3.64 3.82 2.97 0.00 2.10
Debt-free, Cash-free Net Working Capital to Revenue		 -1.36% 1.71% -0.07% -1.41% -4.67% -6.09% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 168.22% 170.96% 159.97% 133.53% 117.84% 101.95% 0.00% 0.00%
Net Working Capital to Revenue		 167.46% 168.84% 156.52% 129.19% 113.09% 45.97% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.37) ($0.25) ($0.21) ($0.22) ($0.27) ($0.24) ($0.12) ($0.07)
Adjusted Weighted Average Basic Shares Outstanding		 78.90M 78.31M 79.08M 78.67M 79.15M 79.16M 372.33M 371.54M
Adjusted Diluted Earnings per Share		 ($0.37) ($0.25) ($0.21) ($0.22) ($0.27) ($0.24) ($0.12) ($0.07)
Adjusted Weighted Average Diluted Shares Outstanding		 78.90M 78.31M 79.08M 78.67M 79.15M 79.16M 372.33M 371.54M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 79.30M 79.06M 78.38M 78.96M 79.40M 290.12M 371.15M 372.26M
Normalized Net Operating Profit after Tax (NOPAT)		 -18 -15 -11 -11 -12 -10 -29 -17
Normalized NOPAT Margin		 -69.89% -54.69% -43.04% -38.41% -48.31% -37.02% -79.00% -37.82%
Pre Tax Income Margin		 -117.52% -76.88% -66.01% -60.50% -82.58% -70.73% -122.73% -59.64%
Debt Service Ratios		 - - - - - - - -
EBIT to Interest Expense		 -27.73 -68.82 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 -19.37 -12.42 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -28.94 -69.45 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -20.57 -13.05 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -7.05% -6.90% -11.92% -6.42% -7.66% -7.25% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Financial Performance Overview for Standard BioTools (NASDAQ:LAB)

Standard BioTools continues to show significant challenges in profitability with persistent net losses over the last several quarters. Despite revenues increasing from approximately $25.6 million in Q3 2022 to about $44.97 million in Q3 2024, the company remains unprofitable, reporting consolidated net losses of around $34 million in Q4 2024 and similar negative results in prior quarters.

Key Positive Factors:

  • Revenue growth from approximately $25.6 million in Q3 2022 to $44.97 million in Q3 2024, reflecting increased market demand and sales capacity.
  • Substantial cash and equivalents holdings, with cash balance rising from $60.2 million in Q3 2022 to $210.6 million by Q3 2024, enhancing liquidity.
  • Increase in short-term investments from $0 in Q2 2023 to $155.7 million in Q3 2024, indicating strong cash management and investment strategy.
  • Gross profit improvement aligned with revenue growth, gross profit rising from approximately $9.2 million in Q3 2022 to $23.3 million (Q3 2024 LTM) showcasing operational scaling potential.

Neutral Factors to Watch:

  • Depreciation and amortization expenses have been relatively stable, around $3 million per quarter, covering the company's asset use and intangible amortization.
  • Stock count has significantly increased from roughly 79 million shares in 2022 to over 370 million shares in 2024, reflecting dilution which may impact per-share metrics.
  • Non-cash adjustments and changes in operating assets and liabilities have shown some volatility, affecting cash flow from operations.

Key Negative Factors:

  • Consistent substantial net losses: For example, a loss of $34 million in Q4 2024 and similar losses in preceding quarters point to ongoing profitability struggles.
  • Operating expenses remain significantly higher than gross profit, with total operating expenses nearly $55 million in Q3 2024 versus gross profit of $23.3 million, pressuring operating margins.
  • Negative net cash flow from operating activities, with over $27.9 million used in operating cash flow in Q3 2024, indicating cash burn from core business operations.
  • High restructuring charges in recent quarters, exemplified by $7.4 million in Q3 2024, reflecting ongoing efforts to adjust cost structure but also incurring heavy one-time expenses.
  • Significant repayment of debt ($55 million in Q4 2024) impacting cash reserves and highlighting debt servicing burden.
  • Elevated research and development expenses (over $13 million in Q3 2024) with limited return yet, contributing to losses.

Summary: Standard BioTools has demonstrated promising revenue growth and has built a strong liquidity position through growing cash and investments. However, the company's persistent net losses, high operating and restructuring costs, and negative operating cash flow underscore ongoing challenges in achieving profitability. Dilution from share issuance further impacts earnings per share metrics. Investors should watch for improvements in operational efficiency and sustainable profitability trends in upcoming quarters.

10/26/25 07:58 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Fluidigm's Financials

When does Fluidigm's financial year end?

According to the most recent income statement we have on file, Fluidigm's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Fluidigm's net income changed over the last 3 years?

Fluidigm's net income appears to be on an upward trend, with a most recent value of -$138.89 million in 2024, rising from -$59.24 million in 2021. The previous period was -$74.66 million in 2023.

What is Fluidigm's operating income?
Fluidigm's total operating income in 2024 was -$175.24 million, based on the following breakdown:
  • Total Gross Profit: $84.26 million
  • Total Operating Expenses: $259.50 million
How has Fluidigm's revenue changed over the last 3 years?

Over the last 3 years, Fluidigm's total revenue changed from $130.58 million in 2021 to $174.43 million in 2024, a change of 33.6%.

How much debt does Fluidigm have?

Fluidigm's total liabilities were at $140.62 million at the end of 2024, a 12.0% decrease from 2023, and a 22.1% decrease since 2021.

How much cash does Fluidigm have?

In the past 3 years, Fluidigm's cash and equivalents has ranged from $28.45 million in 2021 to $166.73 million in 2024, and is currently $166.73 million as of their latest financial filing in 2024.

How has Fluidigm's book value per share changed over the last 3 years?

Over the last 3 years, Fluidigm's book value per share changed from 1.24 in 2021 to 1.27 in 2024, a change of 2.5%.


Related Companies

This page (NASDAQ:FLDM) was last updated on 10/26/2025 by MarketBeat.com Staff
From Our Partners
U.S. Government Sparking Crypto Rally
Missed Bitcoin when it was $100? You’re not alone. Crypto runs in cycles—and the next one is already underw...
Crypto 101 Media | Sponsoredtc pixel
A Worldwide Gold Lockdown Is Now Underway
Central banks around the world are hoarding gold at one of the fastest rates in history — and former Goldman S...
Stansberry Research | Sponsoredtc pixel
Elon Musk is on the line
Elon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...
Altimetry | Sponsoredtc pixel
Trump’s new nightmare begins
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel
The strategy that wins no matter where the market goes
Joel and Adam have built a crypto trading system with a 93% win rate — even through volatile, sideways markets...
Crypto Swap Profits | Sponsoredtc pixel
If You Keep Cash In A U.S. Bank Account… Read This NOW
The Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...
Banyan Hill Publishing | Sponsoredtc pixel
The End of Elon Musk…?
While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the...
Brownstone Research | Sponsoredtc pixel
This gold stock is STILL undervalued by 80%...
“Like buying gold for $1,000/oz” If you could go back in time to 10+ years ago and buy gold for $1,000 an o...
Golden Portfolio | Sponsoredtc pixel